NASDAQ:ADXS
Delisted

Advaxis Stock Signals

etoro logo Buy ADXS
*Your capital is at risk
$0.604
+0 (+0%)
At Close: May 01, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Advaxis

General

Signal Type Signal Value Data
Score 0.000 75 days ( -187.40 %
Last Price $0.604 0 %
Performance History
7 Days
$0.604 $0.604
0%
30 Days
$0.604 $0.604
0%
12 Mos
$0.110 $0.604
447.44%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 30.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.604 - $0.604
Trend - 3 mos 0.514 % High Width: 5.66 %
Pred. range - 3 mos $0.576 - $0.609 Low -4.56 % - 0.84 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Apr 30, 2026 - 2 days
RSI Short Pivot Signal Buy Very Low Feb 18, 2026 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 79.92
Signal Type Signal Value Importance Data
Trend - 12 mos 673.49 % Very High Width: 193.07 %
Pred. range - 12 mos $2.08 - $6.08 High 244.01 % - 908.19 %
Short MA 12 mos Buy Very High Jan 06, 2026 - 81 days
Long MA 12 mos Buy Very High Dec 31, 2025 - 84 days
Short/Long MA 12 mos Buy Very High Sep 22, 2025 - 155 days
Pivot Long Sell Low Apr 30, 2026 - 2 days
RSI Long Pivot Signal Buy Low Feb 27, 2026 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ADVAXIS
Advaxis
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE